What Lexeo Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 17 |
| Total trades | 6 | 30 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 7,130 | 482,573 |
| Disposed | 8,766 | 142,557 |
| Net activity | −1,636 | +340,016 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bhalla Narinder Pal | Chief Medical Officer | Sep 14 | Grant / award · A | +2,714 | $3.58 | +$9.71K | 84,908 |
| Otero Jose Manuel | Chief Operating Officer | Sep 14 | Grant / award · A | +2,110 | $2.64 | +$5.58K | 138,288 |
| Townsend Richard Nolan | Chief Executive Officer | Sep 14 | Grant / award · A | +2,306 | $2.64 | +$6.1K | 376,778 |
| Townsend Richard Nolan | Chief Executive Officer | Aug 18 | Open-market sale · S | −3,345 | $4.95 | −$16.6K | 374,472 |
| Otero Jose Manuel | Chief Operating Officer | Aug 18 | Open-market sale · S | −1,304 | $4.96 | −$6.46K | 136,178 |
| Tamayo Louis Edward | Chief Financial Officer | Aug 18 | Open-market sale · S | −4,117 | $4.91 | −$20.2K | 92,907 |
| Bhalla Narinder Pal | Chief Medical Officer | Jul 01 | Open-market sale · S | −22,306 | $4.42 | −$98.6K | 82,194 |
| Townsend Richard Nolan | Chief Executive Officer | Jul 01 | Open-market sale · S | −25,947 | $4.48 | −$116K | 377,817 |
| Otero Jose Manuel | Chief Operating Officer | Jul 01 | Open-market sale · S | −4,666 | $4.48 | −$20.9K | 137,482 |
| Tamayo Louis Edward | Chief Financial Officer | Jul 01 | Open-market sale · S | −4,641 | $4.49 | −$20.8K | 97,024 |
| Bhalla Narinder Pal | Chief Medical Officer | Jun 29 | Grant / award · A | +55,000 | — | — | 104,500 |
| Townsend Richard Nolan | Chief Executive Officer | Jun 29 | Grant / award · A | +67,000 | — | — | 403,764 |
| Otero Jose Manuel | Chief Operating Officer | Jun 29 | Grant / award · A | +12,060 | — | — | 142,148 |
| Tamayo Louis Edward | Chief Financial Officer | Jun 29 | Grant / award · A | +12,000 | — | — | 101,665 |
| Otero Jose Manuel | Chief Operating Officer | May 18 | Open-market sale · S | −1,302 | $5.07 | −$6.61K | 130,088 |
| Townsend Richard Nolan | Chief Executive Officer | May 18 | Open-market sale · S | −3,342 | $5.06 | −$16.9K | 336,764 |
| Townsend Richard Nolan | Chief Executive Officer | Apr 06 | Open-market sale · S | −55,000 | $5.69 | −$313K | 340,106 |
| Otero Jose Manuel | Chief Operating Officer | Mar 13 | Grant / award · A | +5,930 | $2.64 | +$15.7K | 131,390 |
| Townsend Richard Nolan | Chief Executive Officer | Mar 13 | Grant / award · A | +2,623 | $2.64 | +$6.94K | 395,106 |
| Townsend Richard Nolan | Chief Executive Officer | Feb 18 | Open-market sale · S | −10,173 | $6.38 | −$64.9K | 392,483 |
Loading...
